Skip to main content
Log in

Risperidone may be the most cost-effective atypical antipsychotic for the treatment of acute manic episodes in bipolar I disorder,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Meletiche DM, Meyer K, Franklin M, Poston S, Grogg AL.Cost-effectiveness of atypical antipsychotics in the treatment of acute mania. 159th Annual Meeting of the American Psychiatric Association: 398 (plus poster) abstr. NR959, 20 May 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Risperidone may be the most cost-effective atypical antipsychotic for the treatment of acute manic episodes in bipolar I disorder,. Pharmacoecon. Outcomes News 507, 7 (2006). https://doi.org/10.2165/00151234-200605070-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605070-00012

Keywords

Navigation